The Management and Outcomes of Male Breast Cancer
| Autor: | Zübeyir Bozdağ, Hatice Gümüş, Ömer Uslukaya, Ahmet Türkoğlu, Metehan Gümüş |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Oncology
medicine.medical_specialty business.industry medicine.medical_treatment Modified Radical Mastectomy Ductal carcinoma medicine.disease Metastasis 03 medical and health sciences 0302 clinical medicine Breast cancer 030220 oncology & carcinogenesis Invasive lobular carcinoma Male breast cancer Internal medicine medicine Breast-conserving surgery Original Article 030212 general & internal medicine business Mastectomy |
| Zdroj: | Journal of Breast Health. 12:165-170 |
| ISSN: | 2149-1976 |
| DOI: | 10.5152/tjbh.2016.3073 |
| Popis: | Objective Due to a lack of sufficient data, the treatment protocols for male breast cancer are usually the same as those used for female breast cancer. The aim of the current study was to present our clinical experience with male breast cancer. Materials and methods The records of 37 patients who were treated for male breast cancer in our hospital between 2004 and 2014 were reviewed retrospectively. The data of patients were recorded and analyzed. Results The mean age of the patients was 63.03±12.36 years. Thirty-three patients (89.2%) had invasive ductal carcinoma, two (5.4%) had ductal carcinoma in situ, and two had invasive lobular carcinoma (5.4%). The most common molecular subtype was luminal A (17 cases, 45.9%). Twenty-nine patients with male breast cancer underwent mastectomy and two underwent breast conserving surgery. Axillary lymph node dissection was performed in 25 patients. The most common surgical procedure was modified radical mastectomy. Distant metastases were present in 17 (45.9%) patients. Overall, the 5-year survival was 60%. The 5-year survival was 100% for those with stage 0-I disease, 87% for stage II, and 42% for stage III. The 3-year survival was 14% for stage IV. Conclusion Patients with male breast cancer presented at an older age, a later stage, and with earlier metastasis. Early metastasis and death increases with increasing stage. Poor prognosis correlates with late admission. Data from different centers should be compiled and reviewed in order to determine a specific treatment protocol for male breast cancer; each paper published reveals new data. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|